Zalka is a 28 year long fellow of the American Academy of Dermatology, as well as the Dermatologic Surgery Society and the Connecticut State Dermatology and Dermatologic Surgery Society, where she also served as a past president
It goes back to the effects that the GLP-1 medications have on appetite control
A patient on Zepbound or Mounjaro does not have this alternative yet
And now that GLP-1 prescriptions have become the hot topic for weight loss, supplement companies are jumping on the bandwagon with products claiming they can do the same thing
GLP-1 receptor belongs to class B1 of the G-protein-coupled receptors (GPCR), a subfamily characterized by not only a large N-terminal extracellular ligand binding domain and seven-transmembrane topology, but also a cAMP-mediated intracellular signaling pathway
Conversely, in another phase 2b study involving patients with T2DM, tirzepatide showed significantly better efficacy in glucose control and weight loss compared to both placebo and dulaglutide, with an acceptable safety and tolerability profile (111)